{"id":45662,"date":"2022-06-29T22:01:57","date_gmt":"2022-06-29T20:01:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/"},"modified":"2022-06-29T22:01:57","modified_gmt":"2022-06-29T20:01:57","slug":"akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/","title":{"rendered":"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK"},"content":{"rendered":"
\n

LONDON–(BUSINESS WIRE)–#akanda<\/a>–Akanda Corp. (“Akanda” or the \u201cCompany\u201d) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (\u201cCanMart\u201d) has partnered with Phlo Connect and Cellen Life Sciences (\u201cCellen\u201d) to create a first-of-its-kind fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens CanMart\u2019s existing partnership with Cellen\u2019s digital Leva Clinic and expands its route to market in the UK with a dispensing model that is also fully digital while at the same time improving the experience for UK medical cannabis patients.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nPhlo Connect integrates digitally with CanMart, Akanda\u2019s UK-based, fully licensed pharmaceutical importer and distributor, to quickly and conveniently deliver prescriptions to patients throughout the United Kingdom. Initially, patients will secure prescriptions through the Leva Clinic, with product transferred through CanMart to Phlo Connect. Patients can then schedule delivery to their home or office. Phlo Connect is the UK\u2019s leading API driven digital pharmacy infrastructure provider that seamlessly connects prescribers, pharmacies and patients for an end-to-end digital experience. Phlo Connect offers a 120-minute delivery service in London and Birmingham and next-day delivery across the UK. This process will be increasingly seamless for patients in the near future as Phlo Connect, Leva Clinic, and CanMart build additional digital interconnections.\n<\/p>\n

\n\u201cAkanda is committed to expanding access to high quality products for anyone in need, and that is qualified in the United Kingdom, a growing market for medical cannabis,\u201d commented Tej Virk, CEO of Akanda. \u201cPhlo Connect and Cellen are the ideal partners to make this happen, combining the UK\u2019s first fully digital pharmacy with a digital dispensing model that is easy to use, secure, and real-time. Patients can arrange a specialist consultation at www.levaclinic.com<\/a> and seamlessly connect to Phlo Connect\u2019s smartphone app to arrange medical cannabis delivery. In the nascent UK medical cannabis market, patients currently suffer from excess friction as the prescription process, and last mile delivery is disjointed. We firmly believe that our solution is the best way to satisfy patients and get our 1P and 3P-supplied medical cannabis in their hands quickly and conveniently, which will greatly improve the patient experience.\u201d\n<\/p>\n

\n\u201cWe believe partnering with CanMart and Cellen will be a game-changer for medicinal cannabis patients here in the UK. By integrating with both CanMart and Cellen via our API driven pharmacy platform, we believe that this partnership is the first truly end to end digital experience for medicinal cannabis patients in the UK,\u201d commented Adam Hunter, CCO of Phlo Connect.\n<\/p>\n

\nAdded Eric Bystrom, CEO of Cellen, \u201cOur patients require access to new high-quality products without the friction and hassle of traditional dispensing services. This partnership is another example of our continuing efforts to build on our national, established relationships with the wider pharmaceutical community in innovative ways. We believe that CanMart\u2019s access to high quality products as well as Phlo Connect’s extensive capabilities in dispensing will go a long way to helping our service to our patients.\u201d\n<\/p>\n

\nThe digital dispensing solution is now live. Patients interested in exploring the program should visit www.levaclinic.com<\/a> to book a free call with one of our specialists.\n<\/p>\n

\nThe partnership with Phlo Connect builds on CanMart\u2019s existing partnership with Cellen, a health tech company that provides treatment to chronic pain patients through its digital pain clinic, Leva Clinic, as well as through partners including the NHS, Boots and others. The Leva Clinic, regulated by the Care Quality Commission (\u201cCQC\u201d), is one of the first fully digital pain clinics in the UK. Through a multi-disciplinary clinical team of expert clinicians, clinical psychologists, physiotherapists and nurse consultants, the Leva Clinic supports patients through personalized online care plans. Cellen is also a medical cannabis supplier to Project Twenty21, the large-scale medical cannabis observational study monitored by Drug Science that aims to improve access to medical cannabis for those in need.\n<\/p>\n

\nCorporate Update<\/b>\n<\/p>\n

\nAs previously announced, Harvinder Singh, Mohsen Rahimi, Jatinder Dhaliwal and Katharyn Field joined Akanda\u2019s board of directors (the \u201cBoard\u201d), effective June 23, 2022. Each of these new directors brings with them a unique perspective within high growth industries pertaining to supply chain, pharmaceuticals and regulatory measures. Tej Virk continues to serve as Chief Executive Officer of the Company and as part of the five-member Board.\n<\/p>\n

\nConcluded Virk, \u201cAlong with the rest of the Akanda management team, we wanted to extend our gratitude to the former directors for their contributions to our business. The many contributions of our prior Board members were critical in enabling us to reach this inflection point. As we increase our focus on the European market, and near-term opportunities, our new directors bring relevant backgrounds and relationships. Management is excited to collaborate with the new Board to achieve profitable growth. We have never been more confident in Akanda\u2019s future.\u201d\n<\/p>\n

\nAbout Akanda Corp.<\/b>\n<\/p>\n

\nAkanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda\u2019s portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa; Holigen, a Portugal-based cultivator, manufacturer and distributor with a prized EU GMP certified indoor grow facility; and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company\u2019s seed-to-patient supply chain also includes partnerships with Cellen Life Sciences\u2019 Leva Clinic, one of the first fully digital pain clinics in the UK, and Cantourage, which operates a platform for bringing medical cannabis to Europe.\n<\/p>\n

\nConnect with Akanda: Email<\/a> | Website <\/a>| <\/b>LinkedIn<\/a> | Twitter<\/a> | Instagram<\/a>\n<\/p>\n

\nAbout Phlo<\/span><\/b>\n<\/p>\n

\nPhlo Connect is an API driven pharmacy infrastructure platform that partners with other healthcare providers to offer a seamless end to end digital pharmacy experience. Leveraging a network of pharmacies, Phlo offers on-demand delivery of prescriptions at a time and place which suits the patient. You can find out more about Phlo\u2019s infrastructure platform at www.phloconnect.com<\/a> and its on-demand pharmacy service at www.wearephlo.com<\/a>.\n<\/p>\n

\nConnect with Phlo: Email<\/a> | Website <\/a>| <\/b>LinkedIn<\/a> | Twitter<\/a> | Instagram<\/a>\n<\/p>\n

\nAbout Cellen<\/span><\/b>\n<\/p>\n

\nCellen is a UK based healthcare innovation company, improving the health and wellbeing of people living with chronic pain with a focus on Medical Cannabis access. Founded in 2019 by Eric Bystrom and Dr. Benjamin Viaris de Lesegno, Cellen is building integrated solutions to manage chronic pain by combining clinical care, innovation and real-world evidence generation. In November 2020, Cellen launched Leva Clinic, the UK’s first Care Quality Commission (CQC) registered online pain clinic. Leva Clinic provides pain management services to the NHS and Boots UK customers. Cellen was selected as UK Department of International Trade’s 25 ‘One’s to Watch’ for Digital Health, was named a finalist for Tech Nations Diversity and Inclusion Award 2021, and was awarded Outstanding for Well-Led by the CQC in 2022.\n<\/p>\n

\nConnect with Cellen: Email<\/a> | Website<\/a> | Twitter<\/a> | Instagram<\/a>\n<\/p>\n

\nCautionary Note Regarding Forward-Looking Information and Statements<\/span><\/b>\n<\/p>\n

\nThis press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development, market changes and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and\/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor:<\/b>
Matt Chesler, CFA
\n
FNK IR
\n
ir@akandacorp.com<\/a><\/p>\n

Media:
\n
United States:<\/b>
Annie Grant
\n
Allison + Partners
\n
akanda@allisonpr.com<\/a><\/p>\n

Europe:<\/b>
Imogen Saunders
\n
Irvine Partners
\n
imogen@irvinepartners.co.uk<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON–(BUSINESS WIRE)–#akanda–Akanda Corp. (“Akanda” or the \u201cCompany\u201d) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (\u201cCanMart\u201d) has partnered with Phlo Connect and Cellen Life Sciences (\u201cCellen\u201d) to create a first-of-its-kind fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens CanMart\u2019s existing … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45662","6":"format-standard","7":"category-industry"},"yoast_head":"\nAkanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LONDON–(BUSINESS WIRE)–#akanda–Akanda Corp. (“Akanda” or the \u201cCompany\u201d) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (\u201cCanMart\u201d) has partnered with Phlo Connect and Cellen Life Sciences (\u201cCellen\u201d) to create a first-of-its-kind fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens CanMart\u2019s existing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-29T20:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220628005777\/en\/1499225\/21\/Phlo-Leva-checkout-16x9.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK\",\"datePublished\":\"2022-06-29T20:01:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/\"},\"wordCount\":1437,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005777\\\/en\\\/1499225\\\/21\\\/Phlo-Leva-checkout-16x9.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/\",\"name\":\"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005777\\\/en\\\/1499225\\\/21\\\/Phlo-Leva-checkout-16x9.jpg\",\"datePublished\":\"2022-06-29T20:01:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005777\\\/en\\\/1499225\\\/21\\\/Phlo-Leva-checkout-16x9.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628005777\\\/en\\\/1499225\\\/21\\\/Phlo-Leva-checkout-16x9.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/","og_locale":"en_US","og_type":"article","og_title":"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Pharma Trend","og_description":"LONDON–(BUSINESS WIRE)–#akanda–Akanda Corp. (“Akanda” or the \u201cCompany\u201d) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (\u201cCanMart\u201d) has partnered with Phlo Connect and Cellen Life Sciences (\u201cCellen\u201d) to create a first-of-its-kind fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens CanMart\u2019s existing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-29T20:01:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220628005777\/en\/1499225\/21\/Phlo-Leva-checkout-16x9.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK","datePublished":"2022-06-29T20:01:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/"},"wordCount":1437,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220628005777\/en\/1499225\/21\/Phlo-Leva-checkout-16x9.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/","url":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/","name":"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220628005777\/en\/1499225\/21\/Phlo-Leva-checkout-16x9.jpg","datePublished":"2022-06-29T20:01:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220628005777\/en\/1499225\/21\/Phlo-Leva-checkout-16x9.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220628005777\/en\/1499225\/21\/Phlo-Leva-checkout-16x9.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/akandas-canmart-partners-with-phlo-connect-and-cellen-life-sciences-to-dispense-deliver-high-quality-medical-cannabis-products-in-the-uk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Akanda\u2019s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45662"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45662\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}